Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone - An in vivo study

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 2, 2010, Pages 426-432

  Peng, Yi Jie ^a,b   Kau, Yi Chuan ^a,c   Wen, Chin Wei ^a   Liu, Kuo Sheng ^c   Liu, Shih Jung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Amikacin; Biodegradable scleral plugs; Dexamethasone; Endophthalmitis; In vivo animal experiment; Intravitreal sustained release; Polylactide polyglycolide; Vancomycin

Indexed keywords

ANIMALS; ANTIBIOTICS; DISEASES; DRUG THERAPY; EXPERIMENTS; LIPIDS; OPHTHALMOLOGY; SINTERING;

AMIKACIN; ANIMAL EXPERIMENTS; DEXAMETHASONES; ENDOPHTHALMITIS; IN-VIVO; POLY LACTIDE; POLYGLYCOLIDE; SUSTAINED RELEASE; VANCOMYCIN;

BIODEGRADABLE POLYMERS;

AMIKACIN; DEXAMETHASONE; POLYGLACTIN; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BIOMATERIAL; DRUG CARRIER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CONTROLLED STUDY; DRUG IMPLANT; DRUG IMPLANTATION; ENDOPHTHALMITIS; MINIMUM INHIBITORY CONCENTRATION; NECROSIS; NONHUMAN; RABBIT; RETINA DETACHMENT; SCLERA; SCLEROTOMY; SUSTAINED DRUG RELEASE; UVEA; ANATOMY AND HISTOLOGY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; EVALUATION STUDY; MATERIALS TESTING; METABOLISM; PATHOLOGY; PROSTHESES AND ORTHOSES; SURGERY;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BIOCOMPATIBLE MATERIALS; DEXAMETHASONE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOPHTHALMITIS; LACTIC ACID; MATERIALS TESTING; POLYGLYCOLIC ACID; PROSTHESES AND IMPLANTS; RABBITS; SCLERA; SOLVENTS; VANCOMYCIN;

EID: 77953822783     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32697     Document Type: Article

References (28)

1. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study. Arch Ophthalmol 1995; 113:1479-1496.
2. Han D, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF. EVSG. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:1-17. (Pubitemid 26230889)
3. Aguilar HE, Meredith TA, El-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK. Vancomycin levels after intravitreal injection. Retina 1995;15:428-432.
4. Kurz D, Ciulla TA. Novel approaches for retinal drug delivery. Ophthalmol Clin N Am 2002;15:405-410.
5. Matsusue Y, Yamamuro T, Oka M, Shikinami Y, Hyon SH, Ikada Y. In vitro and in vivo studies on bioabsorbable ultrahigh-strength poly(L-lactide) rods. J Biomed Mater Res 1992;26:1553-1567.
6. Liu SJ, Kau YC, Liaw CW, Peng YJ. In-vitro elution of Vancomycin/Amikacin/Steroid from solvent-free biodegradable scleral plugs. Int J Pharm 2009;370:75-80.
7. Fekety R. Vancomycin. Med Clin North Am 1982;66:175-181.
8. Kabins SA, Nathan C. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin. Antimicrob Agents Chemother 1978;14:786-787.
9. Siegel RA, Langer R. Mechanistic studies of macromolecular drug release from macroporous polymers. Models for the flow kinetics of drug release. J Control Release 1990;14:153-167. (Pubitemid 20353565)
10. Nie L, Nicolau DP, Nightingale CH, Browner BC, Quintiliani R. In vitro elution of ofloxacin from a bioabsorbable polymer. Acta Orthop Scand 1995;66:365-368.
11. Zhang X, Wyss UP, Pichora D, Goosen MF. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J Pharm Pharmacol 1994;46:718-724. (Pubitemid 24289659)
12. Yasukawa T, Kimura H, Kunou N, Miyamoto H, Honda Y, Ogura Y, Ikada Y. Biodegradable scleral implant for intravitreal controlled release of ganciclovir. Graefe's Arch Clin Exp Ophthalmol 2000;238:186-190. (Pubitemid 30160491)
13. Kunou N, Ogura Y, Honda Y, Hyon SH, Ikada Y. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. J Biomed Mater Res 2000;51:635-641. (Pubitemid 30450722)
14. Yasukawa T, Kimura H, Tabata Y, Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev 2001;52:25-36. (Pubitemid 32973636)
15. Park J, Bungay PM, Lutz RJ, Augsburger JJ, Millard RW, Roy AS, Banerjee RK. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. J Control Release 2005;105:279-295.
16. Hui M, Kwok AKH, Pang CP, Cheung SW, Lam DSC, Chan RCY. An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous. Eye 2007;21:643-648.
17. Kim H, Lizak MJ, Tansey G, Csaky KG, Robinson MR, Yuan P, Wang NS, Lutz RJ. Study of ocular transport of drugs released from an intravitreal implant using magnetic resonance imaging. Ann Biomed Eng 2005;33:150-164.
18. Henry SL, Seligson D, Mangino P, Popham GJ. Antibioticimpregnated beads. Part I: Bead implantation versus systemic therapy. Orthop Rev 1991;20:242-247.
19. Kobayshi H, Shirake K, Ikadlz Y. Toxicity test of biodegradable polymer by implantation in rabbit cornea. J Biomed Mater Res 1991;26:1463-1476.
20. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective randomized study. Br J Ophthalmol 1999;83:1050-1055. (Pubitemid 29433428)
21. Haider SA, Hassett P, Bron AJ. Intraocular vancomycin levels after intravitreal injection in post cataract extraction endophthalmitis. Retina 2001;21:210-213. (Pubitemid 32531936)
22. Conway BP, Campochiaro PA. Macular injarction after endophthalmitis treated with vitrectomy and antravitreal gentamicin. Arch Ophthalmol 1986;104:367-371.
23. Campochiaro PA, Conway BP. Aminoglycoside toxicity-a survey of retinal specialists. Arch Ophthalmol 1991;109:946-950.
24. D'amico DJ, Caspers-Velu L, Libert J, Shanks E, Schrooyen M, Hanninen LA, Kenyon KR. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol 1985;100:264-275.
25. Naveh N, Weissman C. Corticosteroid treatment of laser retinal damage affects prostaglandin E2 response. Invest Ophthalmol Vis Sci 1990;31:9-13. (Pubitemid 20042459)
26. Flower RJ, Blackwell GJ. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456-459.
27. Mager DE, Moledina N, Jusko WJ. Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation. J Pharm Sci 2003;92:1521-1525.
28. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Arch Ophthalmol 1984;102:598-604.